Blogs

Upcoming Higher Logic Online Community Platform Maintenance

By Katie Nickerson posted 13 hours ago
Be the first person to recommend this.
Higher Logic Platform Maintenance is scheduled for Wednesday, December 6th from 8:00 PM to 9:00 PM ET . This maintenance will impact login sessions for interACT. Maintenance provides enhancement to the site’s login session security. Login sessions established prior to this maintenance period are automatically invalidated, requiring all users to re-authenticate. Any logins performed after this period will be secured with the upgraded encryption mechanism. The amount of disruption expected is limited to requiring each user to re-authenticate—this will occur during the above time window.
0 comments

Last Call for Gene Therapy eLearning Seminar: Access to Content Ends on December 31, 2023

By Charlene Barroga posted 5 days ago
Be the first person to recommend this.
Access to the Gene Therapy eLearning Seminar ends December 31, 2023 .
0 comments

The ACT 44th Annual Meeting Mobile App Is Here—Download Today!

By Elisa Turner posted 26 days ago
Be the first person to recommend this.
0 comments

Free ACT Webinar on December 6: Revisiting Certifications in General Toxicology—ABT/ERT/ATS

By Jennifer Daly posted 26 days ago
Be the first person to recommend this.
Webinar Registration Please forward this invitation to others you feel might be interested in this webinar. View a Past ACT Signature Webinar ▸
0 comments

Check Out These Talking Tox Programs at the Annual Meeting!

By Art Shaw posted 26 days ago
Be the first person to recommend this.
0 comments

Discuss the Latest Toxicology Research—Join Us for the 44th Annual Meeting Poster Session

By William Brock posted 10-26-2023
Be the first person to recommend this.
0 comments

Message from ACT Corporate Partner — Lovelace Biomedical

By Art Shaw posted 10-18-2023
Be the first person to recommend this.
ACT Corporate Partner Message Join us next month, November 2nd, for a webinar hosted by the American Association of Pharmaceutical Scientists that is free to ACT members . Our Senior Director of Scientific Core Laboratories, Phil Kuehl, will present and discuss the current field of inhaled biologics. Dr. Kuehl will detail the current status of multiple publicly disclosed inhaled biological programs to include ASO’s, gene therapies, and other modalities to inform the audience on the current state of the art. Moving then to specific differences in the delivery, evaluation, and analysis related to inhaled biologics. Our webinar, “Delivery of ...
0 comments

44th Annual Meeting Welcome Reception Tickets

By Nancy Rollman posted 10-13-2023
Be the first person to recommend this.
To add a Welcome Reception ticket, email a completed Registration Form to ACT Headquarters .
0 comments

Join ACT at the Awards Ceremony on November 13

By Jeffrey Tepper posted 10-13-2023
Be the first person to recommend this.
0 comments

Message from ACT Corporate Partner — Lilly

By Art Shaw posted 10-11-2023
Be the first person to recommend this.
ACT Corporate Partner Message
0 comments

Message from ACT Corporate Partner — Altasciences

By Art Shaw posted 09-27-2023
Be the first person to recommend this.
ACT Corporate Partner Message Altasciences―A Different Kind of CRO/CDMO Applications of Miniature Swine in Small and Large Molecule Nonclinical Studies The use of miniature swine beyond dermal and wound healing research has grown in recent years due to their availability, anatomical similarities to humans, and lower cost compared to other non-rodent models . With greater characterization of the miniature swine model, increased historical data, and wider regulatory acceptance, this species is well-positioned to replace standard non-rodent species in many safety assessment programs. ...
0 comments

Message from ACT Corporate Partner — Inotiv

By Art Shaw posted 09-20-2023
Be the first person to recommend this.
ACT Corporate Partner Message Safety Pharmacology Services at Inotiv Integrated High-Quality In Vivo Services for Safety Evaluations Safety pharmacology evaluations are essential in assessing acute risks and potential undesirable effects of novel pharmaceuticals as part of IND-enabling programs. Use our deep expertise in drug safety assessment to your advantage. At Inotiv, our team understands the importance and complexity of the drug development process and will be there to guide you to success by offering an integrated safety pharmacology solution that includes respiratory, central nervous ...
0 comments

New ToxChats Podcast: Interviewing and Negotiation 101

By Latoya Allen posted 09-06-2023
Be the first person to recommend this.
A new ToxChats© podcast episode is now available to stream online. Previous ToxChats© episodes are available on the ACT website and select episodes can also be found on iTunes and Google (search ToxChats). Interviewing and Negotiation 101 for Toxicologist Roles in the Biopharmaceutical Industry In this ACT ToxChats© episode, Dr. Meredith Steeves and Mr. Terry Leyden share their perspectives on the current hiring landscape for toxicologist roles in industry, how to find the right fit, tips for transitioning from a bench-based position, and how to prepare for and successfully navigate the interview and negotiation process. Dr. Steeves and ...
0 comments

Thank You to the ACT 2023 Annual Meeting Supporters

By Art Shaw posted 08-31-2023
Be the first person to recommend this.
The American College of Toxicology Sincerely Appreciates the Generous Contributions of Our Annual Meeting Supporters Thank You! as of August 21, 2023 Platinum $10,000+ Gold $5,000–$9,999 Silver $2,500–$4,999 Brock Scientific Consulting, LLC GlaxoSmithKline ITR Laboratories Canada Inc. Lhasa Limited Lovelace Biomedical Research Institute Bronze $1,000–$2,499 ...
0 comments

Practical Application of Toxicology in Drug Development 2023 Virtual Course

By Alan Hoberman posted 08-31-2023
Be the first person to recommend this.
0 comments

Message from ACT Corporate Partner Charles River

By Art Shaw posted 08-30-2023
Be the first person to recommend this.
ACT Corporate Partner Message
0 comments

Message from ACT Corporate Partner — Noble Life Sciences

By Art Shaw posted 08-23-2023
Be the first person to recommend this.
ACT Corporate Partner Message Top 3 Mistakes Made During IND Enabling Studies: How a CRO Can Help You Avoid Them Uncover common mistakes during IND enabling studies and learn how preclinical Contract Research Organizations (CROs), like Noble Life Sciences , provide crucial expertise to skillfully sidestep these pitfalls. Mistake #1: Inadequate Toxicology Studies Thorough toxicology studies are vital for evaluating safety, mitigating trial risks, and achieving regulatory compliance. CROs with experienced scientific teams and state-of-the-art facilities can help ...
0 comments

Meet the ACT 44th Annual Meeting Plenary Lecturers

By William Brock posted 08-16-2023
Be the first person to recommend this.
0 comments

Results from the Eleventh Triennial Toxicology Salary Survey

By Florence Burleson posted 08-07-2023
Be the first person to recommend this.
The results from the Eleventh Triennial Toxicology Salary Survey were published in the July/August issue of ACT's International Journal of Toxicology and are now available online. For more than two decades, ACT has participated in the Triennial Toxicology Salary Survey, which provides the toxicology profession with current realistic salary information. Established and grown by the considerable efforts of ACT members Dr. Shayne Gad and Dexter Sullivan, the current survey is the eleventh survey conducted since 1988. Continuing on this tradition, the survey was conducted by the Society of Toxicology's Education and Career Development Committee and Gad ...
0 comments

August 11 is the Last Chance to Join ACT before the Annual Meeting

By Melissa Rhodes posted 08-07-2023
Be the first person to recommend this.
0 comments